July 2026
Published Jul 12, 2026Non Randomized Controlled Trial
This study tested monthly physiotherapist-led exercise guidance supported by wearable device feedback in people with type 2 diabetes, including diabetic kidney disease. Over six months, the intervention group walked farther and had lower HbA1c than the standard care group, while kidney filtration did not clearly change.
Interventions
Exercise therapy
Outcomes
6-minute walk distanceAdverse events incidenceEstimated glomerular filtration rate+3 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effects of zinc gluconate and magnesium oxide as adjuncts to non-surgical periodontal treatment in patients with type 2 diabetes.
Interventions
Non-surgical periodontal treatmentNon-surgical periodontal treatment + Zinc gluconate and Magnesium oxide
Outcomes
Bleeding on probingDentobacterial plaque indexMalondialdehyde (MDA)+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study investigated the effects of aerobic exercise and saffron supplementation on insulin resistance and inflammation in obese women with type 2 diabetes, finding significant improvements in several health markers.
Interventions
Exercise therapy
Outcomes
FibrinogenHomocysteineInsulin resistance+3 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study examined how resistance exercise timing and feeding status affect glycaemic responses in individuals with type 1 diabetes, finding significant differences in glucose levels post-exercise.
Interventions
Resistance training
Outcomes
Blood glucoseTime above rangeTime in range
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study investigated the effects of auricular acupressure on sleep quality and blood glucose levels in elderly individuals with type 2 diabetes, finding significant improvements in both areas.
Interventions
Auricular acupressure
Outcomes
Deep sleep duration (SWS)Glucose iAUC (OGTT)Sleep efficiency+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCT
Interventions
CanagliflozinSitagliptin
Outcomes
Extracellular volumeHbA1cLeft ventricular ejection fraction (LVEF)+3 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effects of canagliflozin on cardiovascular and kidney outcomes in individuals with type 2 diabetes, finding a reduction in major adverse cardiovascular events.
Interventions
Canagliflozin
Outcomes
All-cause mortalityCardiovascular deathComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effects of canagliflozin combined with metformin on cardiovascular risk in patients with type 2 diabetes mellitus, finding a significant reduction in major adverse cardiovascular events.
Interventions
Canagliflozin combined with MetforminMetformin combined with Placebo
Outcomes
Adverse events incidenceAll-cause mortalityBMI+10 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
L-Citrulline supplementation added to standard treatment in adults with type 2 diabetes.
Interventions
L-citrulline supplementation (Phase 1)
Outcomes
Blood glucoseBrachial artery flow-mediated dilation (FMD)Femoral-ankle pulse wave velocity (faPWV)+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the feasibility of continuous glucose monitoring (CGM) in a rural population with type 1 diabetes, finding no significant change in HbA1c levels.
Interventions
Continuous glucose monitoringUsual care
Outcomes
Fidelity of mHealth interventionHbA1cSerious adverse events+1 more
Added to Dediabetes Jul 12, 2026
